Showing posts with label psa. Show all posts
Showing posts with label psa. Show all posts

Medical experts, such as Dr. Brian A. Stone, say African-American men are exceedingly vulnerable to prostate cancer, but that symptoms usually associated with the disease can also be associated with other conditions.

Just in case you didn't know, prostate cancer remains the most commonly diagnosed cancer in American men. Over 200,000 cases are diagnosed and almost 30,000 men die from this disease annually. The bad news is that men of African descent in America die from prostate cancer three times the rate of Caucasians. Prostate cancer is typically a silent invader. The majority of cases are detected based on an abnormal blood test called PSA (prostate specific antigen). The normal range for PSA in a man between 40 and 60 years of age is 0 to 2.5. When this test is elevated, the diagnosis of prostate cancer is made based on a biopsy of the gland. Some patients with prostate cancer develop problems with urination--frequency, waking at night to urinate, a weak flow, severe urgency, hesitation of flow, incomplete emptying, deviated stream and difficulty postponing urination.

The good news is that there are other non-cancerous conditions that can affect the prostate and cause the same symptoms as prostate cancer. The prostate gland is a small, chestnut shaped organ, found only in the male. It is located beneath the bladder and acts as a conduit through which urine flows. The prostate is a part of the urethra, which is the tube that passes from the bladder to the penis. Conditions that affect the urethra can also cause symptoms that can be seen in prostate cancer.

The bladder is a muscular sack that store urine. When it fills with urine, a signal is sent to trigger urination. Conditions that irritate the bladder will cause frequency, urgent urination, waking a night to urinate, loss of control of urine, blood in the urine and burning. These conditions include (but are not limited to) bladder infections, bladder stones, bladder cancer, pelvic radiation, neurological diseases and prostate enlargement.

The prostate begins to enlarge annually when a man reaches his mid-30s. Benign Prostatic Hyperplasia (BPH) affects almost 40 million men in the U.S. This enlargement is a natural component of the aging process that affects more than 70 percent of men in their 70s. Normal cells of the prostate also produce PSA, which can become elevated due to this enlargement. The enlarging prostate compresses the urethra and base of the bladder. This enlargement can result in irritation of the bladder and blockage of the flow of urine. This results in irritation of the bladder with the previously described symptoms. But also weakened flow, dribbling, intermittent flow, hesitancy, incomplete emptying and deviated stream.

The prostate can also become inflamed, resulting in a condition known as prostatitis. This inflammation can be bacterial, viral or idiopathic. Bacterial and viral prostatitis can be the result of a sexually transmitted disease, a urine infection, or any condition that facilitates the entry of bacteria into the prostate gland. Idiopathic prostatitis is inflammation of unknown origin and is probably the most common. This condition can elevate PSA levels and result in irritative and obstructive urination symptoms.

The urethra, below the prostate, can be affected by scar tissue, which is also called stricture disease. This scarring results in narrowing of the urethra and obstruction of the flow of urine. The blockage of normal flow results in the same symptoms as seen in obstruction by an enlarged prostate.

There obviously are several conditions that can affect prostate and urinary tract in men. Black men can be very reluctant when it comes to health issues. All of these conditions are easily treated when identified early in their evolution. However, if untreated, these conditions often result in significant complications, including erectile dysfunction, inability to pass urine, severe infection and in rare cases, kidney failure. Please seek the consultation of a urologist or your primary physician. Ignore theses symptoms and you may find yourself in an emergency room.

Send questions or comments for this column to Talk To EBONY at www.ebonyjet.com, or mail them to HOUSE CALL, EBONY, 820 S. Michigan Ave., Chicago, IL 60605. Answers to all questions are checked with a physician. This information is not intended as a substitute for individual, professional medical treatment. Due to the volume of mail received, we cannot give personal replies.

Bibliography for "'It's not always prostate cancer.'"

Brian A. Stone "'It's not always prostate cancer.'". Ebony. Sept 2007. FindArticles.com. 03 Oct. 2007. http://findarticles.com/p/articles/mi_m1077/is_11_62/ai_n19480187

Read More......

With the advent of the PSA (Prostate Specific Antigen) blood test two decades ago, the screening for and detecting of prostate cancer in the United States has been revolutionized.

Introduction

PSA is a protein manufactured in the prostate. There is an association between the PSA level and the likelihood of the man having prostate cancer.

Previously, the only screening test for prostate cancer was a digital rectal exam. That meant a physician inserted his or her gloved finger into the man’s rectum to determine if he or she felt any lumps or bumps in the prostate gland. By that point, the cancer was relatively far advanced. Fortunately, PSA blood tests can detect a prostate malignancy at a much earlier stage. This is known as a stage shift.

When is a PSA level elevation significant?

As men age, they often develop a non-cancerous increase in the size of the prostate, known as benign prostatic hyperplasia. This also elevates PSA, which leads to controversy as to whether or not to send the man for a prostate biopsy. The latter is an invasive procedure, but it is the method by which prostate cancer is diagnosed.

Over the last twenty years, much research took place to determine what constitutes a normal PSA level. In the '80s and '90s, physicians used a cutoff of a value of 4. However, doctors now know that there is really no "normal" level of PSA. Instead, there are ranges and trends of PSA. Generally, the current acceptable cutoff is 2.5, so any level above 2.5 is considered an abnormal PSA.

The normal level of PSA changes over a man's lifetime. As previously stated, as a man ages, the prostate gland’s volume increases. Thus, the actual cut off point of normal PSA level changes as a function of age.

For men in their 70s, one might accept a level of 2.5 because the likelihood of that person's elevation of PSA being a consequence of benign prostatic hyperplasia is much greater than his likelihood of having prostate cancer. For younger men, it might be worrisome when the PSA rises to 2.5.

PSA level trends

Physicians are also interested in how the PSA level changes over time. For example, a PSA that rose gradually over many years, even if the level itself were over 4, is much less concerning than a number that jumped from 2 to 4 in one year. The rate change of PSA over time is known as the PSA velocity. Also, PSA doubling time is the time it takes for the PSA to go from some level to twice that level.

In a man with prostate cancer, the shorter the PSA doubling time is, the greater the rate of growth of the disease. This is a prognosticator and it suggests the need for medical intervention instead of observation.

PSA level to monitor the activity of prostate cancer

Treatment for early stage prostate cancer is usually local therapy, namely surgery or radiation therapy. When the prostate is removed, PSA levels normally drop to zero. When radiation is used, there may still be some detectable PSA, but at very low levels.

After surgery or radiation, physicians generally check the PSA every three months for a few years. When the PSA level remains stable over time, the likelihood is strong that the person has been cured. Thereafter, doctors can decrease the interval of checking the PSA.

Ongoing measurements of PSA are an important means to follow a person with a history of prostate cancer. While there is controversy about using PSA as a screening tool in the general population, there is none about the value of PSA as a monitoring tool in someone who has been treated for prostate cancer.

When the PSA level climbs over several sequential measurements, it is considered to represent what is called a biochemical failure, PSA-detectable disease, or PSA recurrence. How to manage a PSA recurrence varies from one patient to the next. Certainly, there are men who have a rising PSA after local therapy who will never have any problem with recurrent cancer.

However, there are people who will develop a cancer recurrence, characterized by a rapidly rising PSA before they have detectable cancer on a scan. Aggressive treatments can make a difference in the lives of these men.

Treatment for PSA recurrence

Currently available treatments include the use of hormonal or androgen-deprivation therapy, to prevent the production or action of the male hormone testosterone on prostate cancer cells. This can be achieved via the surgical removal of the testicles, or, more commonly, through the use of hormonal medications.

Unfortunately, hormonal treatments often fail after a period of time, and rising PSA levels may be the first indication. If the PSA is rising, it signifies what is called hormone-refractory prostate cancer. Nonetheless, in this late stage of disease, further treatment is still available.

Over the past year or two, more studies have proven the benefit of chemotherapy in advanced prostate cancer. Not only does chemotherapy prolong life in men with hormone-refractory prostate cancer, but it can also improve their quality of life.

Conclusions

While debate remains about the best use of PSA testing in the population at large, especially for screening, experts agree that PSA and its relationship to prostate cancer has had a significant effect on making treatment decisions for a disease that affects a many men.

Dr. Kornmehl is a board certified radiation oncologist at Passaic Beth Israel Medical Center and author of the critically acclaimed consumer health book, “The Best News About Radiation Therapy” (M. Evans, 2004). Her website is http://www.RTSupportDoc.com.

Article Source: http://EzineArticles.com/?expert=Carol_Kornmehl

Read More......